Related Experiment Video
Updated: May 24, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Cyclophilin A restricts influenza A virus replication through degradation of the M1 protein
Xiaoling Liu1, Zhendong Zhao, Chongfeng Xu
1Center for Molecular Virology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Abstract:
Cyclophilin A (CypA) is a typical member of the cyclophilin family of peptidyl-prolyl isomerases and is involved in the replication of several viruses. Previous studies indicate that CypA interacts with influenza virus M1 protein and impairs the early stage of the viral replication. To further understand the molecular mechanism by which CypA impairs influenza virus replication, a 293T cell line depleted for endogenous CypA was established. The results indicated that CypA inhibited the initiation of virus replication. In addition, the infectivity of influenza virus increased in the absence of CypA. Further studies indicated that CypA had no effect on the stages of virus genome replication or transcription and also did not impair the nuclear export of the viral mRNA. However, CypA decreased the viral protein level. Additional studies indicated that CypA enhanced the degradation of M1 through the ubiquitin/proteasome-dependent pathway. Our results suggest that CypA restricts influenza virus replication through accelerating degradation of the M1 protein.
Insights
Cyclophilin A (CypA) restricts influenza virus replication by promoting the degradation of the M1 protein. Depleting CypA increases influenza virus infectivity and viral protein levels.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Cyclophilin A (CypA) is a peptidyl-prolyl isomerase implicated in the replication of various viruses.
- CypA interacts with the influenza virus M1 protein, potentially hindering early viral replication stages.
Purpose of the Study:
- To elucidate the molecular mechanism by which CypA influences influenza virus replication.
- To investigate the role of CypA in the early stages of influenza virus infection.
Main Methods:
- Established a 293T cell line with depleted endogenous CypA.
- Assessed influenza virus replication, infectivity, and protein levels.
- Investigated the effect of CypA on viral genome replication, transcription, and mRNA nuclear export.
- Examined the impact of CypA on M1 protein degradation via the ubiquitin/proteasome pathway.
Main Results:
- CypA was found to inhibit the initiation of influenza virus replication.
- Influenza virus infectivity was significantly higher in cells lacking CypA.
- CypA did not affect viral genome replication, transcription, or mRNA nuclear export.
- CypA reduced viral protein levels by enhancing M1 protein degradation through the ubiquitin/proteasome pathway.
Conclusions:
- CypA acts as a restriction factor for influenza virus replication.
- The mechanism involves CypA-mediated acceleration of M1 protein degradation.
- Targeting the CypA-M1 interaction could be a strategy for antiviral therapies.
Related Concept Videos
Leaky Scanning
Influenza
Inhibitors of Viral Protein Synthesis
Anaphase Promoting Complex
Positive Regulator Molecules
GPCRs Regulate Adenylyl Cylase Activity
Two...

